Valvular Heart Disease in Antiphospholipid Syndrome

[1]  J. Gris,et al.  Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients , 2009, Annals of the rheumatic diseases.

[2]  M. Khamashta,et al.  Cardiac valve replacement in patients with antiphospholipid syndrome , 2012, Arthritis care & research.

[3]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[4]  M. Saric,et al.  Mitral Valve Libman–Sacks Endocarditis Visualized by Real Time Three‐Dimensional Transesophageal Echocardiography , 2012, Echocardiography.

[5]  Angela Tincani,et al.  International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. , 2012, Arthritis and rheumatism.

[6]  O. Alfieri,et al.  The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique. , 2011, Journal of the American College of Cardiology.

[7]  Soon J. Park,et al.  Primary antiphospholipid antibody syndrome and Libmann-Sachs endocarditis. , 2011, Mayo Clinic proceedings.

[8]  E. de Maistre,et al.  Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus: Meta-Analysis of Echocardiographic Studies , 2011, Circulation.

[9]  Y. Shoenfeld,et al.  Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions , 2011, Lupus.

[10]  H. Chaliki,et al.  Unusual case of nonbacterial thrombotic endocarditis attributable to primary antiphospholipid syndrome. , 2010, Circulation.

[11]  A. Evangelista,et al.  Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients , 2010, Lupus.

[12]  G. Espinosa,et al.  Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  T. Ortel,et al.  Update of the guidelines for lupus anticoagulant detection , 2009, Journal of thrombosis and haemostasis : JTH.

[14]  R. Ca.  Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis. , 2009 .

[15]  M. Gershwin,et al.  Revisiting Libman–Sacks Endocarditis: A Historical Review and Update , 2009, Clinical reviews in allergy & immunology.

[16]  J. Piette,et al.  Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients , 2008, Annals of the rheumatic diseases.

[17]  C. Roldan.  Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis. , 2009, Minerva cardioangiologica.

[18]  G. Ménard.  Establishing the Diagnosis of Libman–Sacks Endocarditis in Systemic Lupus Erythematosus , 2008, Journal of General Internal Medicine.

[19]  H. Gorki,et al.  The antiphospholipid syndrome and heart valve surgery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  Chan Jun-mi,et al.  International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .

[21]  A. Gradman,et al.  Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome--a case-series. , 2007, Heart, lung & circulation.

[22]  P. Sandset,et al.  Activated protein C resistance determined with a thrombin generation‐based test is associated with thrombotic events in patients with lupus anticoagulants , 2007, Journal of thrombosis and haemostasis : JTH.

[23]  H. Moutsopoulos,et al.  Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. , 2007, The American journal of medicine.

[24]  C. Qualls,et al.  Valvular Heart Disease by Transthoracic Echocardiography Is Associated with Focal Brain Injury and Central Neuropsychiatric Systemic Lupus Erythematosus , 2007, Cardiology.

[25]  Primary Aps,et al.  Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk , 2007 .

[26]  R. Devereux,et al.  Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[27]  K. Hashimoto,et al.  A case of mitral valve plasty for Libman-Sacks endocarditis mimicking a cardiac tumor. , 2006, The Journal of thoracic and cardiovascular surgery.

[28]  S. De Castro,et al.  The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement. , 2006, Clinical and experimental rheumatology.

[29]  C. Qualls,et al.  Valvular Heart Disease Is Associated With Nonfocal Neuropsychiatric Systemic Lupus Erythematosus , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[30]  M. Turiel,et al.  Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. , 2005, The American journal of cardiology.

[31]  C. Qualls,et al.  Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. , 2005, The American journal of cardiology.

[32]  G. Sanz,et al.  Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. , 2005, Arthritis and rheumatism.

[33]  J. Chapman,et al.  Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome , 2005 .

[34]  M. Inanç,et al.  Assessment of Cardiac Structure and Left Atrial Appendage Functions in Primary Antiphospholipid Syndrome: A Transesophageal Echocardiographic Study , 2005, Stroke.

[35]  A. Koike,et al.  Does antiphospholipid antibody syndrome affect bioprosthetic heart valve? Midterm echocardiographic report. , 2005, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[36]  M. Soto,et al.  Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. , 2004, The Journal of rheumatology.

[37]  M. Petri.  Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease. , 2004, The Journal of rheumatology.

[38]  D. Mevorach,et al.  Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. , 2004, The Journal of thoracic and cardiovascular surgery.

[39]  O. Pradier,et al.  Thrombosis of aortic valve homograft associated with lupus anticoagulant antibodies. , 2004, The Annals of thoracic surgery.

[40]  Y. Shoenfeld,et al.  Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. , 2004, Thrombosis research.

[41]  R. Priori,et al.  Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus , 2003, Lupus.

[42]  M. Petri,et al.  Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report , 2003, Lupus.

[43]  K. Kuck,et al.  Unusual Manifestation of Libman-Sacks Endocarditis in Systemic Lupus Erythematosus , 2003 .

[44]  K. Kuck,et al.  Images in cardiovascular medicine. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosus. , 2003, Circulation.

[45]  J. Piette,et al.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. , 2002, Arthritis and rheumatism.

[46]  W. Edwards,et al.  Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. , 2001, Mayo Clinic proceedings.

[47]  N. Espinola-Zavaleta,et al.  Two and three-dimensional echocardiography in primary antiphospholipid syndrome: misdiagnosis as rheumatic valve disease , 2001, Lupus.

[48]  M. Vilardell‐Tarrés,et al.  Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. , 2001, Scandinavian journal of rheumatology.

[49]  W. Edwards,et al.  Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. , 2000, Mayo Clinic proceedings.

[50]  M. Turiel,et al.  Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography , 2000, Lupus.

[51]  Y. Shoenfeld,et al.  Intravenous immunoglobulin therapy of antiphospholipid syndrome. , 2000, Rheumatology.

[52]  J. Roelandt,et al.  Images in Cardiovascular Medicine , 2000 .

[53]  J. Ilany,et al.  Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. , 1997, Seminars in arthritis and rheumatism.

[54]  Z. Amoura,et al.  Valvular heart disease and systemic lupus erythematosus. , 1997, The New England journal of medicine.

[55]  Y. Shoenfeld,et al.  Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves , 1996, Lupus.

[56]  Y. Shoenfeld,et al.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. , 1996, Circulation.

[57]  D. Lillicrap,et al.  Thrombotic endocarditis and lupus anticoagulant. A pathogenetic possibility for idiopathic 'rheumatic type' valvular heart disease. , 1989, Archives of pathology & laboratory medicine.

[58]  E. Libman,et al.  A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS , 1924 .